Info
Insider Trading
Financials
Holders

Insider Transactions Reported by 18 Insiders of Protara Therapeutics, Inc.

Symbol: TARA on Nasdaq
Location: New York, NY

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+20,000	49%	$3.19	+$63,800
Sells	1	-21,224	51%	$4.53	-$96,145
Net	0	-1,224	-3%		-$32,345

Protara Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jesse Shefferman	CEO and President, Director	$3,436,391			26 Jun 2025
Opaleye Management Inc.	10%+ Owner	$3,399,232			11 Sep 2024
Jacqueline Zummo	Chf Scientific Operations Off	$447,840	-$96,145	-18%	26 Mar 2025
Leonardo Nicacio	Chief Medical Officer	$236,380			15 Apr 2025
Patrick Fabbio	Chief Financial Officer	$202,010			24 Jan 2025
WILLIAM CONKLING	Chief Commercial Officer	$179,000			02 Jun 2025
Hannah Fry	VP, Controller	$175,225			24 Jan 2025
Richard S. Levy	Director	$162,690	+$63,800	+65%	12 Jun 2025
Jathin Bandari	Chief Medical Officer	$108,305			19 Jan 2024
Blaine Davis	Chief Financial Officer	$39,464			15 Jul 2022
Martin Sebastian Olivo	Chief Medical Officer	$27,397			10 Jun 2021
GREGORY SARGEN	Director				12 Jun 2025
Jane Huang	Director				12 Jun 2025
Barry P. Flannelly	Director				12 Jun 2025
Michael Edward Solomon	Director				12 Jun 2025
Cynthia Smith	Director				12 Jun 2025
LUKE M. BESHAR	Director				12 Jun 2025
ROGER GARCEAU	Director				12 Jun 2025

Recent Insider Transactions by Companies or Individuals for Protara Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.